Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are among the
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …
Bispecific antibodies in lung cancer: a state-of-the-art review
Bispecific antibodies have emerged as a promising class of therapeutics in the field of
oncology, offering an innovative approach to target cancer cells while sparing healthy …
oncology, offering an innovative approach to target cancer cells while sparing healthy …
LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non …
C Yin, J Li, S Li, X Yang, Y Lu, C Wang, B Liu - Cellular Signalling, 2024 - Elsevier
Tumor-associated macrophages (TAMs) mainly exhibit the characteristics of M2-type
macrophages, and the regulation of TAM polarization is a new target for cancer therapy …
macrophages, and the regulation of TAM polarization is a new target for cancer therapy …
Ribavirin attenuates carcinogenesis by downregulating IL-6 and IL-8 in vitro in human lung adenocarcinoma
Lung cancer is one of the leading causes of death worldwide, whereby the major
contributing factors are cigarette smoking and exposure to environmental pollutants. Despite …
contributing factors are cigarette smoking and exposure to environmental pollutants. Despite …
The Interplay Between HIF‐1α and EZH2 in Lung Cancer and Dual‐Targeted Drug Therapy
J Wang, C Yang, H Xu, X Fan, L Jia, Y Du… - Advanced …, 2024 - Wiley Online Library
Interactions between oncogenic proteins contribute to the phenotype and drug resistance.
Here, EZH2 (enhancer of zest homolog 2) is identified as a crucial factor that mediates HIF‐1 …
Here, EZH2 (enhancer of zest homolog 2) is identified as a crucial factor that mediates HIF‐1 …
Nano-formulations for pulmonary delivery: Past, present, and future perspectives
With the development of nanotechnology and confronting the problems of traditional
pharmaceutical formulations in treating lung diseases, inhalable nano-formulations have …
pharmaceutical formulations in treating lung diseases, inhalable nano-formulations have …
Integrated network pharmacology, molecular docking, molecular simulation, and in vitro validation revealed the bioactive components in soy-fermented food products …
Globally, lung cancer remains one of the leading causes of cancer-related mortality,
warranting the exploration of novel and effective therapeutic approaches. Soy-fermented …
warranting the exploration of novel and effective therapeutic approaches. Soy-fermented …
Determination of Antioxidant, Cytotoxicity, and Anti-human Lung Cancer Properties of Silver Nanoparticles Green-Formulated by Foeniculum vulgare Extract …
Q Wu, Z Qin, P Sun, F Liu, Y Ge, P Wang - Biological Trace Element …, 2024 - Springer
The current investigation involved the silver nanoparticles green synthesis utilizing the
aqueous extract derived from the Foeniculum vulgare leaves (AgNPs@ FV). The …
aqueous extract derived from the Foeniculum vulgare leaves (AgNPs@ FV). The …
lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer
Long non-coding RNAs (lncRNAs) have emerged as crucial regulators in various cellular
processes, including cancer progression and stress response. Recent studies have …
processes, including cancer progression and stress response. Recent studies have …
Daidzein nanosuspension in combination with cisplatin to enhance therapeutic efficacy against A549 non-small lung cancer cells: an in vitro evaluation
Lung cancer is the most common cause of cancer-related mortality, chemo-resistance, and
toxicity limit treatment. The focus is on innovative combined phytotherapy to improve …
toxicity limit treatment. The focus is on innovative combined phytotherapy to improve …